NPPA gets GST ready; releases ceiling price of 761 medicines

Drug price regulator NPPA today announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotic, with a majority being reduced ahead of the GST implementation.

The National Pharmaceutical Pricing Authority (NPPA) said however that the actual increase or decrease in prices after the rollout of new indirect tax regime is expected to be in be in the range of 2-3 per cent depending on states.

"In order to facilitate smooth implementation of GST for companies, we have worked out the provisional ceiling prices of 761 formulations," NPPA Chairman Bhupendra Singh told

(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)